title: Long term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer.
authors: Karen L
authors: KL
authors: Wright
authors: Duncan A F
authors: DA
authors: Robertson
authors: Mary P
authors: MP
authors: Moyer
authors: Stephen G
authors: SG
authors: Ward
mesh_terms: D000236:Adenoma / Q000517:prevention & control; D019440:Anti-Obesity Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D002277:Carcinoma / Q000517:prevention & control; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D015179:Colorectal Neoplasms / Q000139:chemically induced* / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D013759:Dronabinol / Q000494:pharmacology; D054314:Drug Inverse Agonism; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000378:metabolism / Q000473:pathology; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009765:Obesity / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D043884:Receptor, Cannabinoid, CB1 / Q000819:agonists* / Q000037:antagonists & inhibitors*; D043885:Receptor, Cannabinoid, CB2 / Q000819:agonists / Q000037:antagonists & inhibitors; D000077285:Rimonabant
chemical_list: D019440:Anti-Obesity Agents; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D013759:Dronabinol; D000077285:Rimonabant